Remnant lipoprotein cholesterol is associated with incident new onset diabetes after transplantation (NODAT) in renal transplant recipients: results of the TransplantLines Biobank and cohort Studies

[1] Montori VM(2002)Posttransplantation diabetes: a systematic review of the literature Diabetes Care 25 583-592

[2] Basu A(2015)Emerging treatments for post-transplantation diabetes mellitus Nat Rev Nephrol 11 465-477

[3] Erwin PJ(2019)Management of kidney transplant recipients by general nephrologists: core curriculum 2019 Am J Kidney Dis 73 866-879

[4] Velosa JA(2014)New-onset diabetes after renal transplantation Diabet Med 31 1284-1292

[5] Gabriel SE(2003)Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients Am J Transplant 3 590-598

[6] Kudva YC(2011)Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2 Curr Opin Lipidol 375 735-742

[7] Jenssen T(2010)Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials Lancet 43 1945-1947

[8] Hartmann A(2020)Statin use is prospectively associated with new-onset diabetes after transplantation in renal transplant recipients Diabetes Care 21 178-185

[9] Voora S(2010)HDL and LDL cholesterol significantly influence β-cell function in type 2 diabetes mellitus Curr Opin Lipidol 68 1915-1923

[10] Adey DB(2019)HDL cholesterol efflux predicts incident new-onset diabetes after transplantation (NODAT) in renal transplant recipients independent of HDL cholesterol levels Diabetes 28 300-307

[1] Montori VM(2002)Posttransplantation diabetes: a systematic review of the literature Diabetes Care 25 583-592

[2] Basu A(2015)Emerging treatments for post-transplantation diabetes mellitus Nat Rev Nephrol 11 465-477

[3] Erwin PJ(2019)Management of kidney transplant recipients by general nephrologists: core curriculum 2019 Am J Kidney Dis 73 866-879

[4] Velosa JA(2014)New-onset diabetes after renal transplantation Diabet Med 31 1284-1292

[5] Gabriel SE(2003)Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients Am J Transplant 3 590-598

[6] Kudva YC(2011)Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2 Curr Opin Lipidol 375 735-742

[7] Jenssen T(2010)Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials Lancet 43 1945-1947

[8] Hartmann A(2020)Statin use is prospectively associated with new-onset diabetes after transplantation in renal transplant recipients Diabetes Care 21 178-185

[9] Voora S(2010)HDL and LDL cholesterol significantly influence β-cell function in type 2 diabetes mellitus Curr Opin Lipidol 68 1915-1923

[10] Adey DB(2019)HDL cholesterol efflux predicts incident new-onset diabetes after transplantation (NODAT) in renal transplant recipients independent of HDL cholesterol levels Diabetes 28 300-307